{"Welcome.html": {"id": "Welcome.html", "text": "Welcome", "displayed_text": "Welcome"}, "Task.html": {"id": "Task.html", "text": "Task", "displayed_text": "Task"}, "Generalization.html": {"id": "Generalization.html", "text": "Generalization", "displayed_text": "Generalization"}, "Generalization Examples.html": {"id": "Generalization Examples.html", "text": "Generalization Examples", "displayed_text": "Generalization Examples"}, "Navigation.html": {"id": "Navigation.html", "text": "Navigation", "displayed_text": "Navigation"}, "Consent.html": {"id": "Consent.html", "text": "Consent", "displayed_text": "Consent"}, "Medicine_56": {"DOI": "10.1001/jama.2014.15690", "id": "Medicine_56", "News Finding": "At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).", "Paper Finding": "The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54).", "News Context": "The researchers found that there was no statistically significant difference between the two groups in time to the primary end point (a composite of death from cardiovascular causes, nonfatal stroke, and nonfatal heart attack). At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent). Aspirin significantly reduced incidence of nonfatal heart attack and transient ischemic attack, and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization.", "Paper Context": "Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and 5 in the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% CI, 0.19-0.47] for aspirin vs 0.58 [95% CI, 0.42-0.81] for no aspirin; HR, 0.53 [95% CI, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% CI, 0.16-0.42] for aspirin vs 0.49 [95% CI, 0.35-0.69] for no aspirin; HR, 0.57 [95% CI, 0.32-0.99]; P = .04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% CI, 0.67-1.11] for aspirin vs 0.51 [95% CI, 0.37-0.72] for no aspirin; HR, 1.85 [95% CI, 1.22-2.81]; P = .004).", "scores": "[5.0, 5.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.75, "source": "news", "News URL": "http://www.newswise.com/articles/effect-of-once-daily-low-dose-aspirin-on-cv-death-and-other-outcomes", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: The researchers found that there was no statistically significant difference between the two groups in time to the primary end point (a composite of death from cardiovascular causes, nonfatal stroke, and nonfatal heart attack). At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent). Aspirin significantly reduced incidence of nonfatal heart attack and transient ischemic attack, and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization.\"><b>Finding A:</b></span> At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and 5 in the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% CI, 0.19-0.47] for aspirin vs 0.58 [95% CI, 0.42-0.81] for no aspirin; HR, 0.53 [95% CI, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% CI, 0.16-0.42] for aspirin vs 0.49 [95% CI, 0.35-0.69] for no aspirin; HR, 0.57 [95% CI, 0.32-0.99]; P = .04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% CI, 0.67-1.11] for aspirin vs 0.51 [95% CI, 0.37-0.72] for no aspirin; HR, 1.85 [95% CI, 1.22-2.81]; P = .004).\"><b>Finding B:</b></span> The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54).']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: The researchers found that there was no statistically significant difference between the two groups in time to the primary end point (a composite of death from cardiovascular causes, nonfatal stroke, and nonfatal heart attack). At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent). Aspirin significantly reduced incidence of nonfatal heart attack and transient ischemic attack, and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization.\"><b>Finding A:</b></span> At 5 years after randomization, the cumulative primary event rate was similar in participants in the aspirin group (2.77 percent) and those in the no aspirin group (2.96 percent).<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Patients with an occurrence of nonfatal stroke totaled 114 in the aspirin group and 108 in the no aspirin group; of nonfatal myocardial infarction, 20 in the aspirin group and 38 in the no aspirin group; of undefined cerebrovascular events, 3 in the aspirin group and 5 in the no aspirin group. The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54). Aspirin significantly reduced incidence of nonfatal myocardial infarction (0.30 [95% CI, 0.19-0.47] for aspirin vs 0.58 [95% CI, 0.42-0.81] for no aspirin; HR, 0.53 [95% CI, 0.31-0.91]; P = .02) and transient ischemic attack (0.26 [95% CI, 0.16-0.42] for aspirin vs 0.49 [95% CI, 0.35-0.69] for no aspirin; HR, 0.57 [95% CI, 0.32-0.99]; P = .04), and significantly increased the risk of extracranial hemorrhage requiring transfusion or hospitalization (0.86 [95% CI, 0.67-1.11] for aspirin vs 0.51 [95% CI, 0.37-0.72] for no aspirin; HR, 1.85 [95% CI, 1.22-2.81]; P = .004).\"><b>Finding B:</b></span> The 5-year cumulative primary outcome event rate was not significantly different between the groups (2.77% [95% CI, 2.40%-3.20%] for aspirin vs 2.96% [95% CI, 2.58%-3.40%] for no aspirin; hazard ratio [HR], 0.94 [95% CI, 0.77-1.15]; P = .54)."}, "Medicine_tweet_13": {"DOI": "10.1002/cncr.30564", "id": "Medicine_tweet_13", "News Finding": "Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  ", "Paper Finding": "Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status.", "News Context": "Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  ", "Paper Context": "Concern over sexual, but not nonsexual, HPV transmission to partners was reported by 50%. Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status. From baseline to 6 months, significant increases in abstinence from vaginal sex (from 10% to 34%; P <.01) and oral sex (from 25% to 80%; P <.01) were reported.", "scores": "[5.0, 2.0, 1.0, 3.0, 5.0]", "field": "Medicine", "split": "val", "final_score": 5.0, "source": "tweets", "News URL": "834783376150249472", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  \"><b>Finding A:</b></span> Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Concern over sexual, but not nonsexual, HPV transmission to partners was reported by 50%. Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status. From baseline to 6 months, significant increases in abstinence from vaginal sex (from 10% to 34%; P <.01) and oral sex (from 25% to 80%; P <.01) were reported.\"><b>Finding B:</b></span> Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  \"><b>Finding A:</b></span> Diagnosis and treatment of #oralcancer are assoc w/ changes in sexual behavior, regardless of tumor #HPV status  <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Concern over sexual, but not nonsexual, HPV transmission to partners was reported by 50%. Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status. From baseline to 6 months, significant increases in abstinence from vaginal sex (from 10% to 34%; P <.01) and oral sex (from 25% to 80%; P <.01) were reported.\"><b>Finding B:</b></span> Significant declines in the frequency of vaginal and oral sexual behaviors were reported at follow-up, regardless of tumor HPV status."}, "Medicine_402": {"DOI": "10.1007/s10484-015-9286-9", "id": "Medicine_402", "News Finding": "\"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton.", "Paper Finding": "In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction.", "News Context": "With recent support from the Food and Drug Administration on what could be the first-ever approved drug for the treatment of female sexual dysfunction, the researchers believe that HRV could be used as an index of drug-related changes in sexual function. \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton. \"It makes it easier to talk about something a little bit more private and get women the help that they need.\"", "Paper Context": "Women with below average HRV were significantly more likely to report sexual arousal dysfunction (p \\ .001) and overall sexual dysfunction (p \\ .001) than both women with average HRV and women with above average HRV. In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction. Given these findings, it is reasonable to expect ANS activity (indexed by HRV) may be related to women's self-reported, real-life sexual arousal function outside of the laboratory.", "scores": "[4.0, 5.0, 4.0, 4.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.2, "source": "news", "News URL": "http://www.newswise.com/articles/study-links-heartbeat-to-female-libido", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: With recent support from the Food and Drug Administration on what could be the first-ever approved drug for the treatment of female sexual dysfunction, the researchers believe that HRV could be used as an index of drug-related changes in sexual function. \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman\\'s risk for sexual dysfunction,\" said Stanton. \"It makes it easier to talk about something a little bit more private and get women the help that they need.\"\"><b>Finding A:</b></span> \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman\\'s risk for sexual dysfunction,\" said Stanton.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Women with below average HRV were significantly more likely to report sexual arousal dysfunction (p \\\\ .001) and overall sexual dysfunction (p \\\\ .001) than both women with average HRV and women with above average HRV. In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction. Given these findings, it is reasonable to expect ANS activity (indexed by HRV) may be related to women\\'s self-reported, real-life sexual arousal function outside of the laboratory.\"><b>Finding B:</b></span> In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: With recent support from the Food and Drug Administration on what could be the first-ever approved drug for the treatment of female sexual dysfunction, the researchers believe that HRV could be used as an index of drug-related changes in sexual function. \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton. \"It makes it easier to talk about something a little bit more private and get women the help that they need.\"\"><b>Finding A:</b></span> \"Because evidence shows that low HRV is a potential risk factor for sexual dysfunction, physicians have a simple, low-cost and nonintrusive method to measure a woman's risk for sexual dysfunction,\" said Stanton.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Women with below average HRV were significantly more likely to report sexual arousal dysfunction (p \\ .001) and overall sexual dysfunction (p \\ .001) than both women with average HRV and women with above average HRV. In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction. Given these findings, it is reasonable to expect ANS activity (indexed by HRV) may be related to women's self-reported, real-life sexual arousal function outside of the laboratory.\"><b>Finding B:</b></span> In conclusion, low HRV may be a risk factor for female sexual arousal dysfunction and overall sexual dysfunction."}, "Medicine_tweet_24": {"DOI": "10.1001/jamainternmed.2018.2259", "id": "Medicine_tweet_24", "News Finding": "Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  ", "Paper Finding": "Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage.", "News Context": "Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  ", "Paper Context": "Findings In this randomized clinical trial of 512 adults, the proportion achieving ureteral stone expulsion by 28 days was 50% with tamsulosin vs 47% with placebo, a nonsignificant difference. Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage. In the 11 cases for which this algorithm did not yield a clear result, the CT scans were individually reviewed and a consensus was reached.", "scores": "[5.0, 4.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 4.666666666666667, "source": "tweets", "News URL": "1008762116805808134", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  \"><b>Finding A:</b></span> Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Findings In this randomized clinical trial of 512 adults, the proportion achieving ureteral stone expulsion by 28 days was 50% with tamsulosin vs 47% with placebo, a nonsignificant difference. Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage. In the 11 cases for which this algorithm did not yield a clear result, the CT scans were individually reviewed and a consensus was reached.\"><b>Finding B:</b></span> Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  \"><b>Finding A:</b></span> Tamulosin is often used in patients with kidney stones in the hope it will speed stone passage.  This RCT shows it is ineffective.  <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Findings In this randomized clinical trial of 512 adults, the proportion achieving ureteral stone expulsion by 28 days was 50% with tamsulosin vs 47% with placebo, a nonsignificant difference. Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage. In the 11 cases for which this algorithm did not yield a clear result, the CT scans were individually reviewed and a consensus was reached.\"><b>Finding B:</b></span> Meaning For emergency department patients who present with renal colic owing to ureteral stones smaller than 9 mm, tamsulosin does not appear to promote stone passage."}, "Medicine_401": {"DOI": "10.1371/journal.pone.0193399", "id": "Medicine_401", "News Finding": "For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident's interests.", "Paper Finding": "Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident's interests (5%, n = 234).", "News Context": "advertisement\n\nPositive behaviours were reported to be much more common than abusive behaviours, however some positive but time-consuming behaviours were notably infrequent. For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident's interests. v\"Carers can't just be told that care should be person-centred -- they need to be given the support and training that will enable them to deliver it,\" she said.", "Paper Context": "Most staff reported positive care behaviours, but specific person-centred activities were sometimes infrequent. Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident's interests (5%, n = 234). 763 (5%; 95% Confidence Interval (CI) 47% to 54%) of care home staff reported carrying out or observing potentially abusive or neglectful behaviours at least sometimes in the preceding 3 months; some abuse was reported as happening \"at least sometimes\" in 9/92 care homes.", "scores": "[3.0, 5.0, 5.0, 5.0]", "field": "Medicine", "split": "val", "final_score": 4.5, "source": "news", "News URL": "http://ct.moreover.com/?a=33617077814&p=1pl&v=1&x=ohjazzVxcRa1ao0LE5QCcQ", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: advertisement\\n\\nPositive behaviours were reported to be much more common than abusive behaviours, however some positive but time-consuming behaviours were notably infrequent. For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident\\'s interests. v\"Carers can\\'t just be told that care should be person-centred -- they need to be given the support and training that will enable them to deliver it,\" she said.\"><b>Finding A:</b></span> For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident\\'s interests.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Most staff reported positive care behaviours, but specific person-centred activities were sometimes infrequent. Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident\\'s interests (5%, n = 234). 763 (5%; 95% Confidence Interval (CI) 47% to 54%) of care home staff reported carrying out or observing potentially abusive or neglectful behaviours at least sometimes in the preceding 3 months; some abuse was reported as happening \"at least sometimes\" in 9/92 care homes.\"><b>Finding B:</b></span> Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident\\'s interests (5%, n = 234).']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: advertisement\n\nPositive behaviours were reported to be much more common than abusive behaviours, however some positive but time-consuming behaviours were notably infrequent. For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident's interests. v\"Carers can't just be told that care should be person-centred -- they need to be given the support and training that will enable them to deliver it,\" she said.\"><b>Finding A:</b></span> For instance, more than one in three care home staff were rarely aware of a resident being taken outside of the home for their enjoyment, and 15% said activities were almost never planned around a resident's interests.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Most staff reported positive care behaviours, but specific person-centred activities were sometimes infrequent. Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident's interests (5%, n = 234). 763 (5%; 95% Confidence Interval (CI) 47% to 54%) of care home staff reported carrying out or observing potentially abusive or neglectful behaviours at least sometimes in the preceding 3 months; some abuse was reported as happening \"at least sometimes\" in 9/92 care homes.\"><b>Finding B:</b></span> Many care home staff were never or almost never aware of a resident being taken out of the home for their enjoyment (34%, n = 520); or an activity planned around a resident's interests (5%, n = 234)."}, "Medicine_tweet_1": {"DOI": "10.1001/jamaophthalmol.2017.4816", "id": "Medicine_tweet_1", "News Finding": "Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. ", "Paper Finding": "The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present.", "News Context": "Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. ", "Paper Context": "Findings In this single-center cohort study of 49 448 outpatient ophthalmology appointments by 33 attending physicians, appointments with residents and fellows were 32% and 30% longer, respectively, than appointments without trainees. The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present. Meaning Academic medical centers face potential challenges in maintaining clinical efficiency and medical education, particularly in emerging value-based reimbursement models.", "scores": "[5.0, 5.0, 5.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 5.0, "source": "tweets", "News URL": "928668516101902337", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. \"><b>Finding A:</b></span> Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Findings In this single-center cohort study of 49 448 outpatient ophthalmology appointments by 33 attending physicians, appointments with residents and fellows were 32% and 30% longer, respectively, than appointments without trainees. The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present. Meaning Academic medical centers face potential challenges in maintaining clinical efficiency and medical education, particularly in emerging value-based reimbursement models.\"><b>Finding B:</b></span> The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. \"><b>Finding A:</b></span> Trainees in clinic associated w longer appointment times, even for patients not seen by a trainee. <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Findings In this single-center cohort study of 49 448 outpatient ophthalmology appointments by 33 attending physicians, appointments with residents and fellows were 32% and 30% longer, respectively, than appointments without trainees. The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present. Meaning Academic medical centers face potential challenges in maintaining clinical efficiency and medical education, particularly in emerging value-based reimbursement models.\"><b>Finding B:</b></span> The presence of a trainee in a clinic session was associated with longer mean appointment times, even in appointments in which the trainee was not present."}, "test_question_testing_They are at the same level of generality": {"id": "test_question_testing_They are at the same level of generality", "text": "<b>Finding A:</b> Magnesium potentially has many health benefits.<br><b>Finding B:</b> This is a test question, please select They are at the same level of generality.", "displayed_text": "<b>Finding A:</b> Magnesium potentially has many health benefits.<br><b>Finding B:</b> This is a test question, please select They are at the same level of generality."}, "Medicine_104": {"DOI": "10.14814/phy2.13617", "id": "Medicine_104", "News Finding": "On evenings when using light-emitting tablets, participants' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset.", "Paper Finding": "A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children.", "News Context": "On evenings when using light-emitting tablets, participants' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset. When using the tablets, participants rated themselves as less sleepy in the evenings and less alert in the first hour after awakening on the following mornings. \"These findings provide more evidence that light-emitting electronic devices have biological effects,\" said co-author Dr. Jeanne Duffy, of Brigham and Women's Hospital and Harvard Medical School.", "Paper Context": "To our knowledge, this study is the first to quantify the melatonin suppression response to evening light exposure in healthy 3-to 5-year-old children. A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children. Findings from this study mark an important step in addressing a gap in understanding the melatonin suppression response across the lifespan.", "scores": "[4.0, 4.0, 3.0]", "field": "Medicine", "split": "train", "final_score": 3.6666666666666665, "source": "news", "News URL": "http://ct.moreover.com/?a=34124049276&p=1pl&v=1&x=KTWUvvClkwVOoq-BQDOMVw", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: On evenings when using light-emitting tablets, participants\\' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset. When using the tablets, participants rated themselves as less sleepy in the evenings and less alert in the first hour after awakening on the following mornings. \"These findings provide more evidence that light-emitting electronic devices have biological effects,\" said co-author Dr. Jeanne Duffy, of Brigham and Women\\'s Hospital and Harvard Medical School.\"><b>Finding A:</b></span> On evenings when using light-emitting tablets, participants\\' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: To our knowledge, this study is the first to quantify the melatonin suppression response to evening light exposure in healthy 3-to 5-year-old children. A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children. Findings from this study mark an important step in addressing a gap in understanding the melatonin suppression response across the lifespan.\"><b>Finding B:</b></span> A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: On evenings when using light-emitting tablets, participants' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset. When using the tablets, participants rated themselves as less sleepy in the evenings and less alert in the first hour after awakening on the following mornings. \"These findings provide more evidence that light-emitting electronic devices have biological effects,\" said co-author Dr. Jeanne Duffy, of Brigham and Women's Hospital and Harvard Medical School.\"><b>Finding A:</b></span> On evenings when using light-emitting tablets, participants' self-selected bedtimes were on average half an hour later, and they showed suppressed melatonin levels, delayed timing of melatonin secretion onset, and later sleep onset.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: To our knowledge, this study is the first to quantify the melatonin suppression response to evening light exposure in healthy 3-to 5-year-old children. A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children. Findings from this study mark an important step in addressing a gap in understanding the melatonin suppression response across the lifespan.\"><b>Finding B:</b></span> A combination of well-controlled procedures minimizing sources of error variance, a repeated-measures design, and large effect sizes led to several significant findings: (a) 1-h of bright light exposure before bedtime suppresses melatonin by~88%; (b) the effects of evening bright light exposure on melatonin levels persisted at least 50-min following termination of the light stimulus; and (c) melatonin levels remained attenuated and did not return to 50% of those observed in the dim light condition following the bright light exposure for the majority of the children."}, "Medicine_240": {"DOI": "10.1210/jc.2013-2350", "id": "Medicine_240", "News Finding": "Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.", "Paper Finding": "In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS .", "News Context": "\"The Society's recommendations allow physicians to make the diagnosis if clear symptoms are present without resorting to universal hormone tests or ultrasound screening.\" In the CPG, The Endocrine Society recommends that a diagnosis be made if adult women have two of the three cardinal features of PCOS (diagnostic criteria supported by the NIH panel): * Excess production of male hormones called androgens. Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.", "Paper Context": "Women with PCOS should have BMI and blood pressure measured at each clinic visit (and consider waist circumference if nonobese; \u0546 36 inches is abnormal), and upon diagnosis of PCOS, additional testing should include a complete fasting lipid profile (total cholesterol, LDL-cholesterol, non-HDL-cholesterol, HDL-cholesterol, and triglycerides). In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS . Another marker of atherosclerosis, coronary artery calcification, is more common in women with PCOS than in controls, even after adjusting for the effects of age and BMI .", "scores": "[4.0, 4.0, 2.0, 5.0]", "field": "Medicine", "split": "train", "final_score": 3.75, "source": "news", "News URL": "http://www.sciencedaily.com/releases/2013/10/131024121206.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: \"The Society\\'s recommendations allow physicians to make the diagnosis if clear symptoms are present without resorting to universal hormone tests or ultrasound screening.\" In the CPG, The Endocrine Society recommends that a diagnosis be made if adult women have two of the three cardinal features of PCOS (diagnostic criteria supported by the NIH panel): * Excess production of male hormones called androgens. Other recommendations from the CPG include:\\n\\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\\n\\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\\n\\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\\n\\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\\n\\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\\n\\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.\"><b>Finding A:</b></span> Other recommendations from the CPG include:\\n\\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\\n\\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\\n\\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\\n\\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\\n\\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\\n\\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Women with PCOS should have BMI and blood pressure measured at each clinic visit (and consider waist circumference if nonobese; \u0546 36 inches is abnormal), and upon diagnosis of PCOS, additional testing should include a complete fasting lipid profile (total cholesterol, LDL-cholesterol, non-HDL-cholesterol, HDL-cholesterol, and triglycerides). In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS . Another marker of atherosclerosis, coronary artery calcification, is more common in women with PCOS than in controls, even after adjusting for the effects of age and BMI .\"><b>Finding B:</b></span> In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS .']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: \"The Society's recommendations allow physicians to make the diagnosis if clear symptoms are present without resorting to universal hormone tests or ultrasound screening.\" In the CPG, The Endocrine Society recommends that a diagnosis be made if adult women have two of the three cardinal features of PCOS (diagnostic criteria supported by the NIH panel): * Excess production of male hormones called androgens. Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.\"><b>Finding A:</b></span> Other recommendations from the CPG include:\n\n* Because women with PCOS face an increased risk of pregnancy complications such as gestational diabetes, preterm delivery and preeclampsia that can be exacerbated by obesity, women should have their body mass index, blood pressure and oral glucose tolerance assessed prior to conceiving;\n\n* Following diagnosis, women with PCOS should be examined for skin and hair complications including excess hair growth and acne;\n\n* Although women with PCOS have some of the same risk factors associated with the development of endometrial cancer, they should not routinely undergo ultrasound screening for endometrial thickness;\n\n* To gauge metabolic risk, adolescents and adult women with PCOS should be screened for increased obesity using body mass index and waist circumference measurements;\n\n* Clinicians should give adolescents and adult women with PCOS an oral glucose tolerance test to check for type 2 diabetes or impaired glucose tolerance because they are at increased risk of these conditions; and\n\n* Initial treatment of type 2 diabetes or impaired glucose tolerance in women with PCOS should be diet and exercise, with metformin as a second-line therapy.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Women with PCOS should have BMI and blood pressure measured at each clinic visit (and consider waist circumference if nonobese; \u0546 36 inches is abnormal), and upon diagnosis of PCOS, additional testing should include a complete fasting lipid profile (total cholesterol, LDL-cholesterol, non-HDL-cholesterol, HDL-cholesterol, and triglycerides). In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS . Another marker of atherosclerosis, coronary artery calcification, is more common in women with PCOS than in controls, even after adjusting for the effects of age and BMI .\"><b>Finding B:</b></span> In addition, the nocturnal drop in mean arterial blood pressure is lower, a finding that has also been demonstrated in obese adolescents with PCOS ."}, "Medicine_tweet_19": {"DOI": "10.1001/jamapediatrics.2018.0302", "id": "Medicine_tweet_19", "News Finding": "Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" ", "Paper Finding": "Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality.", "News Context": "Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" ", "Paper Context": "CONCLUSIONS AND RELEVANCE Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality. Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality. Low vitamin D level status during pregnancy may expose the offspring to a suboptimal nutritional environment during critical phases of fetal development and may have long-term effects on offspring health outcomes.", "scores": "[5.0, 5.0, 4.0, 4.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 4.4, "source": "tweets", "News URL": "1001608339808108544", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" \"><b>Finding A:</b></span> Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: CONCLUSIONS AND RELEVANCE Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality. Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality. Low vitamin D level status during pregnancy may expose the offspring to a suboptimal nutritional environment during critical phases of fetal development and may have long-term effects on offspring health outcomes.\"><b>Finding B:</b></span> Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" \"><b>Finding A:</b></span> Study: \"Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality.\" <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: CONCLUSIONS AND RELEVANCE Vitamin D supplementation during pregnancy is associated with a reduced risk of SGA and improved infant growth without risk of fetal or neonatal mortality or congenital abnormality. Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality. Low vitamin D level status during pregnancy may expose the offspring to a suboptimal nutritional environment during critical phases of fetal development and may have long-term effects on offspring health outcomes.\"><b>Finding B:</b></span> Vitamin D supplementation with doses of 2000 IU/d or lower during pregnancy may reduce the risk of fetal or neonatal mortality."}, "Medicine_216": {"DOI": "10.1016/j.celrep.2016.08.013", "id": "Medicine_216", "News Finding": "By calculating the displacement of bacteria from the endothelial cells, the researchers also found that the microbes use bungee-cord-like tethers to stabilize and strengthen these bonds.", "Paper Finding": "This finding suggested that motility is possibly strong enough to modulate the force imposed on load-bearing bonds and drive active bacterial migration over endothelia under PCV shear stress.", "News Context": "\"Our in vitro live-cell-imaging-based system will permit more efficient dissection of the underlying interaction mechanisms and more rapid screening for inhibitors of bacterial-endothelial interactions and dissemination.\" By calculating the displacement of bacteria from the endothelial cells, the researchers also found that the microbes use bungee-cord-like tethers to stabilize and strengthen these bonds. Similar to children swinging on monkey bars, the bacteria transferred force from one bond to the next without fully detaching, slowing down every time they established a new bond and accelerating when they broke a bond and transitioned to the next one.", "Paper Context": "Thus, unexpectedly, B. burgdorferi experienced forces that were small enough to be overcome by bacterial motility. This finding suggested that motility is possibly strong enough to modulate the force imposed on load-bearing bonds and drive active bacterial migration over endothelia under PCV shear stress. We also found that average bond forces for BBK32-producing GCB966 were larger than for bbk32-deficient GCB971 ( Figure 4B ), that most GCB966 interactions occurred at higher bond forces than GCB971 ( Figure 4C ), and that GCB966 interactions occurred at a higher average shear stress and shear stress range than GCB971 interactions ( Figures 4D and 4E ).", "scores": "[4.0, 4.0, 2.0, 4.0]", "field": "Medicine", "split": "train", "final_score": 3.5, "source": "news", "News URL": "https://www.sciencedaily.com/releases/2016/08/160825130027.htm", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: \"Our in vitro live-cell-imaging-based system will permit more efficient dissection of the underlying interaction mechanisms and more rapid screening for inhibitors of bacterial-endothelial interactions and dissemination.\" By calculating the displacement of bacteria from the endothelial cells, the researchers also found that the microbes use bungee-cord-like tethers to stabilize and strengthen these bonds. Similar to children swinging on monkey bars, the bacteria transferred force from one bond to the next without fully detaching, slowing down every time they established a new bond and accelerating when they broke a bond and transitioned to the next one.\"><b>Finding A:</b></span> By calculating the displacement of bacteria from the endothelial cells, the researchers also found that the microbes use bungee-cord-like tethers to stabilize and strengthen these bonds.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Thus, unexpectedly, B. burgdorferi experienced forces that were small enough to be overcome by bacterial motility. This finding suggested that motility is possibly strong enough to modulate the force imposed on load-bearing bonds and drive active bacterial migration over endothelia under PCV shear stress. We also found that average bond forces for BBK32-producing GCB966 were larger than for bbk32-deficient GCB971 ( Figure 4B ), that most GCB966 interactions occurred at higher bond forces than GCB971 ( Figure 4C ), and that GCB966 interactions occurred at a higher average shear stress and shear stress range than GCB971 interactions ( Figures 4D and 4E ).\"><b>Finding B:</b></span> This finding suggested that motility is possibly strong enough to modulate the force imposed on load-bearing bonds and drive active bacterial migration over endothelia under PCV shear stress.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: \"Our in vitro live-cell-imaging-based system will permit more efficient dissection of the underlying interaction mechanisms and more rapid screening for inhibitors of bacterial-endothelial interactions and dissemination.\" By calculating the displacement of bacteria from the endothelial cells, the researchers also found that the microbes use bungee-cord-like tethers to stabilize and strengthen these bonds. Similar to children swinging on monkey bars, the bacteria transferred force from one bond to the next without fully detaching, slowing down every time they established a new bond and accelerating when they broke a bond and transitioned to the next one.\"><b>Finding A:</b></span> By calculating the displacement of bacteria from the endothelial cells, the researchers also found that the microbes use bungee-cord-like tethers to stabilize and strengthen these bonds.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Thus, unexpectedly, B. burgdorferi experienced forces that were small enough to be overcome by bacterial motility. This finding suggested that motility is possibly strong enough to modulate the force imposed on load-bearing bonds and drive active bacterial migration over endothelia under PCV shear stress. We also found that average bond forces for BBK32-producing GCB966 were larger than for bbk32-deficient GCB971 ( Figure 4B ), that most GCB966 interactions occurred at higher bond forces than GCB971 ( Figure 4C ), and that GCB966 interactions occurred at a higher average shear stress and shear stress range than GCB971 interactions ( Figures 4D and 4E ).\"><b>Finding B:</b></span> This finding suggested that motility is possibly strong enough to modulate the force imposed on load-bearing bonds and drive active bacterial migration over endothelia under PCV shear stress."}, "Medicine_27": {"DOI": "10.1038/s41467-017-01957-8", "id": "Medicine_27", "News Finding": "Less diversity\n\nIn addition, the researchers demonstrated that predator diversity decreases when there is a dynamical trade-off.", "Paper Finding": "Interestingly, the predator diversity does not monotonically increase with prey diversity due to the dynamical trade-off.", "News Context": "In contrast, if the predator cannot adapt, the prey requires fewer resources for defence and can invest more in producing progeny\", explains Becks. Less diversity\n\nIn addition, the researchers demonstrated that predator diversity decreases when there is a dynamical trade-off. The ciliates thus develop fewer different types in order to adapt to bacterial associations and biofilms.", "Paper Context": "This ultimately leads to a lower prey diversity compared to only prey evolution. Interestingly, the predator diversity does not monotonically increase with prey diversity due to the dynamical trade-off. Together, our experimental and theoretical results show that dynamical trade-offs arise and significantly affect the evolution and maintenance of intraspecific diversity.", "scores": "[3.0, 4.0, 4.0, 3.0]", "field": "Medicine", "split": "train", "final_score": 3.5, "source": "news", "News URL": "http://feedproxy.google.com/~r/TechnologyOrg/~3/5JFO6NDeMfE/", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: In contrast, if the predator cannot adapt, the prey requires fewer resources for defence and can invest more in producing progeny\", explains Becks. Less diversity\\n\\nIn addition, the researchers demonstrated that predator diversity decreases when there is a dynamical trade-off. The ciliates thus develop fewer different types in order to adapt to bacterial associations and biofilms.\"><b>Finding A:</b></span> Less diversity\\n\\nIn addition, the researchers demonstrated that predator diversity decreases when there is a dynamical trade-off.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: This ultimately leads to a lower prey diversity compared to only prey evolution. Interestingly, the predator diversity does not monotonically increase with prey diversity due to the dynamical trade-off. Together, our experimental and theoretical results show that dynamical trade-offs arise and significantly affect the evolution and maintenance of intraspecific diversity.\"><b>Finding B:</b></span> Interestingly, the predator diversity does not monotonically increase with prey diversity due to the dynamical trade-off.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: In contrast, if the predator cannot adapt, the prey requires fewer resources for defence and can invest more in producing progeny\", explains Becks. Less diversity\n\nIn addition, the researchers demonstrated that predator diversity decreases when there is a dynamical trade-off. The ciliates thus develop fewer different types in order to adapt to bacterial associations and biofilms.\"><b>Finding A:</b></span> Less diversity\n\nIn addition, the researchers demonstrated that predator diversity decreases when there is a dynamical trade-off.<br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: This ultimately leads to a lower prey diversity compared to only prey evolution. Interestingly, the predator diversity does not monotonically increase with prey diversity due to the dynamical trade-off. Together, our experimental and theoretical results show that dynamical trade-offs arise and significantly affect the evolution and maintenance of intraspecific diversity.\"><b>Finding B:</b></span> Interestingly, the predator diversity does not monotonically increase with prey diversity due to the dynamical trade-off."}, "test_question_testing_Finding B": {"id": "test_question_testing_Finding B", "text": "<b>Finding A:</b> Magnesium potentially has many health benefits.<br><b>Finding B:</b> This is a test question, please select Finding B.", "displayed_text": "<b>Finding A:</b> Magnesium potentially has many health benefits.<br><b>Finding B:</b> This is a test question, please select Finding B."}, "Medicine_tweet_11": {"DOI": "10.1073/pnas.1509654112", "id": "Medicine_tweet_11", "News Finding": "Male and female brains are more similar than previously thought. Interesting paper in PNAS ", "Paper Finding": "Here we show that, although there are sex/gender differences in brain and behavior, humans and human brains are comprised of unique \"mosaics\" of features, some more common in females compared with males, some more common in males compared with females, and some common in both females and males.", "News Context": "Male and female brains are more similar than previously thought. Interesting paper in PNAS ", "Paper Context": "Such an alignment may be predicted by the classic view of sexual differentiation of the brain, according to which masculinization and defeminization of the brain are under the sole influence of testosterone (9). Here we show that, although there are sex/gender differences in brain and behavior, humans and human brains are comprised of unique \"mosaics\" of features, some more common in females compared with males, some more common in males compared with females, and some common in both females and males. Our results demonstrate that regardless of the cause of observed sex/gender differences in brain and behavior (nature or nurture), human brains cannot be categorized into two distinct classes: male brain/female brain.", "scores": "[5.0, 1.0, 4.0, 3.0]", "field": "Medicine", "split": "train", "final_score": 5.0, "source": "tweets", "News URL": "671443107045621761", "text": "['<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Male and female brains are more similar than previously thought. Interesting paper in PNAS \"><b>Finding A:</b></span> Male and female brains are more similar than previously thought. Interesting paper in PNAS <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Such an alignment may be predicted by the classic view of sexual differentiation of the brain, according to which masculinization and defeminization of the brain are under the sole influence of testosterone (9). Here we show that, although there are sex/gender differences in brain and behavior, humans and human brains are comprised of unique \"mosaics\" of features, some more common in females compared with males, some more common in males compared with females, and some common in both females and males. Our results demonstrate that regardless of the cause of observed sex/gender differences in brain and behavior (nature or nurture), human brains cannot be categorized into two distinct classes: male brain/female brain.\"><b>Finding B:</b></span> Here we show that, although there are sex/gender differences in brain and behavior, humans and human brains are comprised of unique \"mosaics\" of features, some more common in females compared with males, some more common in males compared with females, and some common in both females and males.']", "displayed_text": "<span id=\"hover_text_news\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Reporting context: Male and female brains are more similar than previously thought. Interesting paper in PNAS \"><b>Finding A:</b></span> Male and female brains are more similar than previously thought. Interesting paper in PNAS <br><span id=\"hover_text_paper\" data-toggle=\"tooltip\" data-html=\"true\" data-placement=\"bottom\" title=\"Paper context: Such an alignment may be predicted by the classic view of sexual differentiation of the brain, according to which masculinization and defeminization of the brain are under the sole influence of testosterone (9). Here we show that, although there are sex/gender differences in brain and behavior, humans and human brains are comprised of unique \"mosaics\" of features, some more common in females compared with males, some more common in males compared with females, and some common in both females and males. Our results demonstrate that regardless of the cause of observed sex/gender differences in brain and behavior (nature or nurture), human brains cannot be categorized into two distinct classes: male brain/female brain.\"><b>Finding B:</b></span> Here we show that, although there are sex/gender differences in brain and behavior, humans and human brains are comprised of unique \"mosaics\" of features, some more common in females compared with males, some more common in males compared with females, and some common in both females and males."}, "Experience.html": {"id": "Experience.html", "text": "Experience", "displayed_text": "Experience"}, "End.html": {"id": "End.html", "text": "End", "displayed_text": "End"}}